Monday broker round-up
10th Feb 2020 12:52
(Sharecast News) - Consort Medical: RBC Capital Markets upgrades to sector performer with a target price of 1,010p.
Read moreFriday broker round-up
10th Jan 2020 12:57
(Sharecast News) - Polymetal International: Berenberg upgrades to buy with a target price of 1,480p.
Read moreMonday broker round-up
18th Nov 2019 13:24
(Sharecast News) - Croda International: Liberum Capital downgrades to hold with a target price of 4,400p.
Read moreShoreCap downgrades Consort Medical to 'hold' after all-cash offer from Recipharm
18th Nov 2019 10:50
(Sharecast News) - Analysts at ShoreCap downgraded their recommendation for shares of Consort Medical from 'buy' to 'hold' following the recommended cash offer from Recipharm.
Read moreFriday broker round-up
18th Oct 2019 12:53
(Sharecast News) - Royal Bank of Scotland: JP Morgan upgrades to overweight with a target price of 280p.
Read moreConsort Medical signs VapourSoft agreement with Regeneron
18th Oct 2019 10:19
(Sharecast News) - Consort Medical on Friday entered into a development agreement to incorporate its VapourSoft technology into a drug delivery device in partnership with Regeneron Pharmaceuticals.
Read moreSunday share tips: Consort Medical, Weir Group
20th Jan 2019 16:33
(Sharecast News) - In her 'Inside the City' column for the Sunday Times, Sabah Meddings ws looking at pharmaceuticals firm Consort, and how the ongoing government shutdown in the US was affecting its portfolio.
Read moreConsort Medical to take £3m hit from delays to Mylan's Wixela inhaler
4th Dec 2018 10:36
(Sharecast News) - Drug and delivery device company Consort Medical was under the cosh on Tuesday as it warned that pre-tax profit for the current financial year will take a £3m hit from delays to its generic Advair programme.
Read moreConsort Medical pours more cash into Atlas Genetics
23rd Jan 2017 15:23
(ShareCast News) - Single-source drug and delivery device company Consort Medical announced on Monday that it has participated in a further equity raise by Atlas Genetics. The London-listed firm said that, following the successful CE-marking for the chlamydia trachomatis 'io' test cartridge, Atlas G
Read moreConsort Medical splutters as BAT stubs out Voke programme
3rd Jan 2017 08:10
(ShareCast News) - British American Tobacco has terminated an agreement with Consort Medical over the manufacture of nicotine inhalers for its Voke development programme. Consort, which said it was in "constructive dialogue" with BAT's Nicovations arm and product developer Kind Consumer over the fut
Read moreConsort Medical posts good growth in first half
6th Dec 2016 08:18
(ShareCast News) - Single source drug and delivery device company Consort Medical announced its interim results for the six months to 31 October on Tuesday. The London-listed firm said group revenue increased to £144.9m from £135.5m, representing underlying growth of 2.0% and reported growth of 6.9%
Read moreConsort Medical appoints new CFO
25th Nov 2016 09:07
(ShareCast News) - Consort Medical, a global provider of manufacturing solutions for drugs, announced that it has appointed Paul Hayes as group Finance Director of the Vitec Group. Hayes is taking over the position of chief financial officer from Richard Cotton as well joining the board as executive
Read moreConsort Medical's Bespak inks new agreement
14th Oct 2016 12:23
(ShareCast News) - Consort medical, a global single source drug and Delivery device company (CDMO), has announced that its Bespak division has entered into an agreement with a biopharmaceutical company. Bespak manufactures drug delivery devices for pharmaceutical partner companies including respirat
Read moreConsort Medical signs agreement with AstraZeneca
7th Sep 2016 08:43
(ShareCast News) - Consort medical, a provider of advanced technology for drugs, has signed a new contract with pharmaceutical giant AstraZeneca for the supply of its Bespak respiratory devices. AstraZeneca and Bespak have agreed to enter into a multi-year agreement for the scale-up and supply of Be
Read moreDirector dealings: Derwent London CEO sells just ahead of Brexit vote
23rd Jun 2016 15:19
(ShareCast News) - Derwent London chief executive John Burns has sold £1.5m of the FTSE 250 real estate investor's shares in the week just before the EU referendum which could seriously lift or undermine the company's shares. In Wednesday's sale, which comes two days before results for Britain's ref
Read more